NEXGEL, Inc.

NXGLW ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $11.4M $8.7M $4.1M $2.0M $1.6M $674.0K $717.0K $2.2M
Cost of Revenue $6.9M $5.9M $3.7M $1.8M $1.5M $965.0K $854.0K $1.7M
Gross Profit $4.5M $2.7M $374.0K $256.0K $8.0K $-291.0K $-137.0K $514.0K
Gross Margin 39.5% 31.6% 9.1% 12.5% 0.5% -43.2% -19.1% 23.2%
Operating Expenses
Research & Development $2.0K $78.0K $103.0K $367.0K $31.0K — — —
SG&A Expense $7.9M $6.2M $3.7M $3.2M $2.5M $2.0M $1.8M $2.4M
Operating Income $-3.4M $-3.6M $-3.5M $-3.3M $-2.6M $-2.3M $-1.9M $-1.9M
Operating Margin -29.3% -40.9% -85.0% -163.5% -165.7% -335.3% -268.3% -85.3%
Interest Expense — — $15.0K $1.3M — — — —
Pretax Income $-2.9M $-3.5M $-3.2M $-4.7M — — — —
Income Tax Expense — — — $0 $0 $0 $0 —
Net Income $-3.0M $-3.3M $-3.2M $-4.7M $-4.3M $-2.3M $-1.9M $-1.9M
Net Margin -26.3% -37.8% -77.2% -231.7% -277.9% -335.9% -268.2% -85.3%
EPS (Basic) $-0.38 $-0.50 $-0.56 $-0.85 $-1.45 $-1.05 $-0.14 $-0.13
EPS (Diluted) $-0.38 $-0.50 $-0.56 $-0.85 $-1.45 $-1.05 $-0.14 $-0.13
Shares Outstanding (Basic) 7.9M 6.5M 5.7M 5.6M 3.0M 2.3M 13.6M 15.0M
Shares Outstanding (Diluted) 7.9M 6.5M 5.7M 5.6M 3.0M 2.3M 13.6M 15.0M
Dividends Per Share — — — — — — — —